See every side of every news story
Published loading...Updated

Indian Pharma Could Gain Market Share Amid US Tariffs, Says JPMorgan

Summary by NDTV Profit
Indian Pharma may stand to gain market share due to potential impact of US tariffs, according to JPMorgan. In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of manufacturing relocation to the US.This, even as the Nifty Pharma ended in the red for the third session on Thursday.Here are some takeaways from the call.Reciprocal Tariffs Might Pass On To CustomersTariffs of 25% or hig…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

7 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

NDTV Profit broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.